Literature DB >> 30779066

MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.

M Xi1, L Cheng, W Hua, Y-L Zhou, Q-L Gao, J-X Yang, S-Y Qi.   

Abstract

OBJECTIVE: Previous studies have shown that microRNA-95-3p (miR-95-3p) plays a crucial role in multiple human cancers except for prostatic cancer (PCa). Therefore, the function of miR-95-3p was investigated in PCa in the present work. PATIENTS AND METHODS: The expression of miR-95-3p was measured by Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) assay. Western blot assay was used to examine the protein expression of epithelial-mesenchymal transition (EMT) markers. In addition, the function of miR-95-3p was detected through MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and transwell assays. Dual Luciferase assay was applied to confirm the relationship between miR-95-3p and dickkopf-3 (DKK3). The tumor growth was observed through xenograft tumor formation assay.
RESULTS: The upregulation of miR-95-3p was detected in PCa tissues and cell lines, which predicted poor prognosis of PCa patients. Moreover, miR-95-3p promoted cell proliferation, migration and invasion in PCa by targeting DKK3 and activating the Wnt/β-catenin pathway. MiR-95-3p also promoted the tumor growth of PCa in vivo. Besides that, downregulation of DKK3 was identified in PCa and low DKK3 expression predicted poor prognosis of PCa patients.
CONCLUSIONS: MiR-95-3p promoted the development of PCa via targeting DKK3 and activating the Wnt/β-catenin pathway.

Entities:  

Year:  2019        PMID: 30779066     DOI: 10.26355/eurrev_201902_16987

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  HIV-1 Tat and cocaine impact astrocytic energy reservoir influence on miRNA epigenetic regulation.

Authors:  Mayur Doke; Fatah Kashanchi; Mansoor A Khan; Thangavel Samikkannu
Journal:  Genomics       Date:  2021-08-19       Impact factor: 5.736

Review 2.  MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).

Authors:  Yuhe Lei; Lei Chen; Ge Zhang; Aiyun Shan; Chunfeng Ye; Bin Liang; Jiayu Sun; Xin Liao; Changfeng Zhu; Yueyue Chen; Jing Wang; Enxin Zhang; Lijuan Deng
Journal:  Oncol Rep       Date:  2020-07-23       Impact factor: 3.906

3.  Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs.

Authors:  Henriett Butz; Katalin Mészáros; István Likó; Attila Patocs
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

4.  Cabergoline possesses a beneficial effect on blood-brain barrier (BBB) integrity against lipopolysaccharide (LPS).

Authors:  Lina You; Haidong Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  DKK3, Downregulated in Invasive Epithelial Ovarian Cancer, Is Associated with Chemoresistance and Enhanced Paclitaxel Susceptibility via Inhibition of the β-Catenin-P-Glycoprotein Signaling Pathway.

Authors:  Que Thanh Thanh Nguyen; Hwang Shin Park; Tae Jin Lee; Kyung-Mi Choi; Joong Yull Park; Daehan Kim; Jae Hyung Kim; Junsoo Park; Eun-Ju Lee
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

6.  Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β.

Authors:  Shuo Wang; Yudong Cao; Jinchao Ma; Peng Du; Xiao Yang; Ziyi Yu; Yong Yang
Journal:  Cell Death Discov       Date:  2022-08-23

Review 7.  Bargain with the tooth fairy - The savings accounts for dental stem cells.

Authors:  Sophia Julia Häfner
Journal:  Biomed J       Date:  2020-04-22       Impact factor: 4.910

8.  Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

Authors:  Shiwei Guo; Hao Qin; Ke Liu; Huan Wang; Sijia Bai; Shiyi Liu; Zhuo Shao; Yanan Zhang; Bin Song; Xiaoya Xu; Jing Shen; Peng Zeng; Xiaohan Shi; Hao Chen; Suizhi Gao; Jiajia Xu; Yaqi Pan; Lei Xiong; Fugen Li; Dadong Zhang; Xiaodong Jiao; Gang Jin
Journal:  Clin Transl Med       Date:  2021-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.